DAWN: Day One Biopharmaceuticals, Inc. Common Stock Company Profile & Statistics

About

Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.

Info & Links

CEO

Jeremy Bender

Headquarters

1800 Sierra Point Parkway, Suite 200
Brisbane, CA 94005, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

181

Day One Biopharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

710.55M

Enterprise Value

677.19M

Enterprise Value/EBITDA(ttm)

-3.59

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.53

Price to Book(mrq)

1.53

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

92.52%

Operating Margin(ttm)

-42.66%

Profit Margin(ttm)

-89.07%

Return on Equity(ttm)

-14.98%

Return on Invested Capital(ttm)

-15.35%

Return on Assets(ttm)

-13.04%

Income Statement

Revenue(ttm)

161.92M

Revenue Per Share(ttm)

1.60

Gross Profit(ttm)

153.76M

EBITDA(ttm)³

-188.76M

Net Income Available to Common(ttm)

-69.08M

Diluted EPS(ttm)

-0.71

Share Statistics

Beta (5Y Monthly)

-1.27

52-Week Change

-55.31%

S&P 500 52-Week Change

17.04%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

101.36M

Dividend Yield

0.00%

Float⁴

95.08M

% Held by Insiders

6.20%

% Held by Institutions

87.95%

Balance Sheet

Total Cash(mrq)

473.02M

Total Cash Per Share(mrq)

4.67

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

10.62%

Quick Ratio(mrq)

10.55%

Book Value Per Share(mrq)

4.73

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.57

Free Cash Flow(ytd)

-59.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

DAWN

Day One Biopharmaceuticals, Inc. Common Stock

Day One Biopharmaceuticals, Inc. Common Stock Profile